Plasma albumin and calcium concentrations, and long-term mortality in primary health care patients in Sweden.


Journal

Scandinavian journal of primary health care
ISSN: 1502-7724
Titre abrégé: Scand J Prim Health Care
Pays: United States
ID NLM: 8510679

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 24 11 2020
medline: 10 8 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Low plasma (p)-albumin and p-calcium concentrations are associated with increased mortality in hospitalised patients. There are few studies addressing this in primary care. Low p-calcium has been associated with mortality, but it is not known whether this applies to p-albumin. Could p-albumin and p-calcium be used as markers of an increased risk of mortality? To study p-albumin and p-calcium at baseline and their association with mortality after 10-14 years. Prospective cohort study using data from a large primary health care area and the National Swedish Cause of Death Register. Primary health care in Skaraborg, Sweden. 43,052 patients (39.1% men), ≥18 years, 60.7 ± 18.4 years with p-albumin and p-calcium concentrations registered in 2001-2005. P-albumin and p-calcium concentrations at baseline and their association with mortality after a mean follow-up period of 10.3 ± 4.0 years. Low p-albumin was associated with total mortality compared with normal p-albumin, greatest at lower ages (18-47 years). The hazard ratios for women and men were 3.12 (95% CI 1.27-7.70) and 4.09 (95% CI 1.50-11.14), respectively. The increased mortality was seen in both cardiovascular and malignant diseases in both women and men. In contrast, low p-calcium was not associated with increased mortality, 1.00 (95% CI 0.96-1.05). Elevated p-calcium was associated with increased mortality, 1.17 (95% CI 1.13-1.22). Low p-albumin could be a marker of an increased risk of mortality, especially in patients of younger ages. This finding should prompt diagnostic measures in order to identify underlying causes. KEY POINTS Low p-albumin and calcium concentrations have been associated with increased mortality in hospitalised patients, but this is unexplored in primary care patients. A low p-albumin concentration at baseline was a risk marker for mortality; highest in the younger age groups. Increased mortality in both cardiovascular and malignant diseases was seen in both men and women with low compared with normal p-albumin concentrations. Elevated but not low p-calcium concentrations were associated with increased mortality after 10-14 years of follow-up.

Identifiants

pubmed: 33226880
doi: 10.1080/02813432.2020.1843809
pmc: PMC7783069
doi:

Substances chimiques

Serum Albumin 0
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

430-438

Références

Lancet. 1990 Feb 10;335(8685):348-51
pubmed: 1967782
Ann Intensive Care. 2019 Nov 27;9(1):133
pubmed: 31776814
Intern Emerg Med. 2012 Oct;7 Suppl 3:S193-9
pubmed: 23073857
Clin Chem Lab Med. 2010 Feb;48(2):237-48
pubmed: 19943809
JAMA. 1994 Oct 5;272(13):1036-42
pubmed: 8089886
Scand J Prim Health Care. 2006 Sep;24(3):160-5
pubmed: 16923625
J Clin Epidemiol. 2009 Nov;62(11):1202-9
pubmed: 19364635
Scand J Prim Health Care. 2018 Mar;36(1):89-98
pubmed: 29366388
BMC Clin Pathol. 2008 Nov 27;8:12
pubmed: 19038049
Clin Nutr. 2001 Jun;20(3):271-3
pubmed: 11407876
J Am Geriatr Soc. 2005 Jul;53(7):1222-6
pubmed: 16108943
Lancet. 1989 Dec 16;2(8677):1434-6
pubmed: 2574367
PLoS One. 2013 Apr 10;8(4):e61037
pubmed: 23593383
QJM. 2020 Jun 1;113(6):393-398
pubmed: 31747010
Eur J Intern Med. 2013 Dec;24(8):772-8
pubmed: 24011640
Biol Res Nurs. 2019 May;21(3):237-244
pubmed: 30722677
Scand J Clin Lab Invest. 2017 Oct;77(6):442-447
pubmed: 28613958
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):473-482
pubmed: 31852221
Am Surg. 2004 Dec;70(12):1099-102
pubmed: 15663053
Postgrad Med. 2020 May;132(4):385-390
pubmed: 32066311
Scand J Prim Health Care. 2018 Jun;36(2):198-206
pubmed: 29623754
Endocr Res. 2018 May;43(2):116-123
pubmed: 29381079
Ann Clin Biochem. 2016 Jan;53(Pt 1):106-11
pubmed: 26071488
Fam Pract. 2016 Oct;33(5):449-52
pubmed: 27343860
J Nutr Sci Vitaminol (Tokyo). 2007 Feb;53(1):37-42
pubmed: 17484377
Scand J Prim Health Care. 2013 Dec;31(4):248-54
pubmed: 24299047
Scand J Prim Health Care. 1990 Dec;8(4):197-202
pubmed: 2284518

Auteurs

Sofia Dalemo (S)

Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.

Kristina Bengtsson Boström (KB)

Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.

Per Hjerpe (P)

Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH